ramp: phase ib study of rucaparib & enzalutamide in mcrpc
Published 3 years ago • 190 plays • Length 6:49Download video MP4
Download video MP3
Similar videos
-
2:26
caspar: the addition of rucaparib to enzalutamide for the treatment of mcrpc
-
0:39
talapro-2: rpfs and os of talazoparib and enzalutamide in mcrpc
-
14:30
mcrpc care: reducing progression risk by combining enzalutamide and talazoparib
-
2:45
arrow: psma-targeted radioligand therapy plus enzalutamide in mcrpc
-
0:46
ctc hoxb13 rna in mcrpc: abiraterone/enzalutamide impact
-
7:00
comparing the second generation hormone therapies | ask a prostate expert, mark scholz, md
-
5:38
simple yet critical lab thresholds to assure your not insulin resistant - aka “metabolic obesity”.
-
6:06
enzalutamide plus androgen deprivation therapy prolongs survival in men with metastatic hormone-...
-
2:59
triton3 interim os results demonstrate superiority of rucaparib over docetaxel for mcrpc
-
4:35
support for continuing enzalutamide after mcrpc progression | axel merseburger
-
1:44
talapro-2: exposure-safety of talazoparib enzalutamide in mcrpc
-
2:59
niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide
-
2:16
testing the validity of a prognostic model for castration-resistant prostate cancer
-
9:59
profound performance: olaparib vs. enzalutamide or abiraterone for hrr altered mcrpc
-
10:21
profound: olaparib vs enzalutamide or abiraterone for mcrpc with hrr gene alterations
-
0:55
dr. pal on sequencing abiraterone and enzalutamide in mcrpc
-
17:44
new approaches to metastatic hormone sensitive prostate cancer
-
14:14
management of mcrpc in china
-
1:39
dr. howard scher on corticosteroids during treatment with enzalutamide in mcrpc
-
3:55
optimal treatment approaches for mcrpc
-
5:01
talazoparib plus enzalutamide shows improvement in pfs over soc in first-line hrr mcrpc